Quick answers
- What is Sodium iodide i 123 used for?
- The FDA-approved label (Sodium Iodide I 123, Cardinal Health 418, Inc, April 17, 2018) says: “INDICATION AND USE Administration of Sodium Iodide I 123 is indicated as a diagnostic procedure to be used in evaluating thyroid function and/or morphology.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Sodium iodide i 123 have a boxed warning?
- No. None of the 2 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Sodium iodide i 123?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Sodium iodide i 123 been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Sodium iodide i 123?
- 2 companies list prescription products of Sodium iodide i 123 in the FDA NDC Directory, including Cardinal Health 418, Inc and Curium US LLC.
What Sodium iodide i 123 is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
INDICATION AND USE Administration of Sodium Iodide I 123 is indicated as a diagnostic procedure to be used in evaluating thyroid function and/or morphology.
— FDA label: Sodium Iodide I 123, Cardinal Health 418, Inc, effective April 17, 2018. Read the full label on DailyMed →
The FDA has 2 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 2 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Capsule, gelatin coated |
|---|---|
| Route | Oral |
| Prescription products | 4 in the FDA NDC Directory |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Cardinal Health 418, Inc2 products
- Curium US LLC2 products
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA018671 SODIUM IODIDE I 123 | Cardinal Health 418 | May 27, 1982 | 11, latest June 13, 2008 2008: Labeling · 2000: Labeling · 1998: Labeling |
Generic approvals (2)
- ANDA071909Curium · February 28, 1989
- ANDA071910Curium · February 28, 1989
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| SPL set ID of the quoted label | 50415c27-1928-4307-b1dc-648f47edf65d |
|---|---|
| FDA labels (SPL) | 2 |
| FDA applications | NDA018671, 2 ANDA |
| Active ingredients (FDA) | SODIUM IODIDE I-123 |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Sodium Iodide I 123, Cardinal Health 418, Inc, effective April 17, 2018; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →